Evidence map›Paper›PMID 33251170›Full record

ReviewFrontiers in public health2020

Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Sameer Dhingra, Nor Azlina A Rahman, Ed Peile, Motiur Rahman, Massimo Sartelli, Mohamed Azmi Hassali, Tariqul Islam, Salequl Islam, Mainul Haque

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 1 pooled it
20.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 1 synthesis or guideline pooled it, 314 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Occurrence of Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 6 countries.

Sameer DhingraSchool of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago.
Nor Azlina A RahmanDepartment of Physical Rehabilitation Sciences, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Kuantan, Malaysia.
Ed PeileWarwick Medical School, University of Warwick, Coventry, United Kingdom.
Motiur RahmanOxford University Clinical Research Unit, Wellcome Trust Asia Programme, The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Massimo SartelliDepartment of General and Emergency Surgery, Macerata Hospital, Macerata, Italy.
Mohamed Azmi HassaliThe Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Malaysia.
Tariqul IslamUChicago Research Bangladesh, Dhaka, Bangladesh.
Salequl IslamDepartment of Microbiology, Jahangirnagar University, Dhaka, Bangladesh.
Mainul HaqueThe Unit of Pharmacology, Faculty of Medicine and Defence Health, National Defence University of Malaysia, Kuala Lumpur, Malaysia.
International Islamic University Malaysia · MYJahangirnagar University · BDNational Defence University of Malaysia · MYOxford University Clinical Research Unit · VNUniversiti Sains Malaysia · MYUniversity of Chicago Research Bangladesh · BDUniversity of Macerata · ITUniversity of the West Indies · TTUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics changed medical practice by significantly decreasing the morbidity and mortality associated with bacterial infection. However, infectious diseases remain the leading cause of death in the world. There is global concern about the rise in antimicrobial resistance (AMR), which affects both developed and developing countries. AMR is a public health challenge with extensive health, economic, and societal implications. This paper sets AMR in context, starting with the history of antibiotics, including the discovery of penicillin and the golden era of antibiotics, before exploring the problems and challenges we now face due to AMR. Among the factors discussed is the low level of development of new antimicrobials and the irrational prescribing of antibiotics in developed and developing countries. A fundamental problem is the knowledge, attitude, and practice (KAP) regarding antibiotics among medical practitioners, and we explore this aspect in some depth, including a discussion on the KAP among medical students. We conclude with suggestions on how to address this public health threat, including recommendations on training medical students about antibiotics, and strategies to overcome the problems of irrational antibiotic prescribing and AMR.

Indexed as

Anti-Infective AgentsBacterial InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialHumansPublic HealthAnti-Bacterial AgentsAnti-Infective AgentsAMRantibioticsantimicrobial resistanceglobehazardpublic health

Identifiers

PMID33251170
PMCPMC7672122
OpenAlexW3097070695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.